January 6, 2017 — The RECHORD trial allows cardiovascular surgeons to replace damaged string-like tendons, called ...
November 10, 2016 — NeoChord Inc. announced the first use of its DS1000 System in the United States as it enrolled the ...
May 17, 2016 — NeoChord Inc. announced it has received Investigational Device Exemption (IDE) approval from the U.S ...
March 29, 2016 — NeoChord Inc. announced that David H. Adams, M.D., and Michael A. Borger, M.D., Ph.D., will serve as ...
(This article was updated in June 2018) The advent of transcatheter valve repair and replacement technologies is one of ...
April 12, 2013 — NeoChord has received CE mark for its technology that allows the implantation of artificial chordae ...